Revvity Inc vs YieldMax TSLA Option Income Strategy ETF — how do they compare? Revvity Inc trades at $110.7 (market cap $11.87B), while YieldMax TSLA Option Income Strategy ETF trades at $25.64. The key difference: Revvity Inc pays a 0.26% dividend while YieldMax TSLA Option Income Strategy ETF pays none, and Revvity Inc is trading nearer its 52-week high, YieldMax TSLA Option Income Strategy ETF nearer its low. Which is the better fit depends on your goals.
| RVTY | TSLY | |
|---|---|---|
Market Cap | $11.87B | — |
Sector | Technology | Income / Options Overlay |
52-Week High | $117.75 | $48.25 |
52-Week Low | $82.26 | $25.07 |
Enterprise Value | $14.36B | — |
Dividend Yield | 0.26% | — |
Trailing returns across standard periods
Latest headlines on both assets
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →TSLY is an actively managed ETF that seeks to provide high monthly income by employing a synthetic covered call strategy on Tesla, Inc. (TSLA). It does not own Tesla stock directly; instead, it uses a combination of call and put options to simulate long exposure while simultaneously selling call options to collect premiums. It is designed for income-focused investors who are willing to trade TSLA's potential upside for immediate, aggressive yield.
Read more on TSLY →